These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3887433)

  • 1. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
    Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
    Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
    [No Abstract]   [Full Text] [Related]  

  • 2. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
    Lam-Po-Tang PR; McCowage GB; Vowels MR
    Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
    Seeger RC; Villablanca JG; Matthay KK; Harris R; Moss TJ; Feig SA; Selch M; Ramsay N; Reynolds CP
    Prog Clin Biol Res; 1991; 366():527-33. PubMed ID: 2068169
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.
    D'Angio GJ; August C; Elkins W; Evans AE; Seeger R; Lenarsky C; Feig S; Wells J; Ramsay N; Kim T
    Prog Clin Biol Res; 1985; 175():557-63. PubMed ID: 3887431
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of neuroblastoma: role of total body irradiation].
    Franzone P; Corvò R; Dini G; Perin GP; Scarpati D
    Radiol Med; 1986 Dec; 72(12):959-62. PubMed ID: 3541069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT.
    Hartmann O; Kalifa C; Beaujean F; Bayle C; Benhamou E; Lemerle J
    Prog Clin Biol Res; 1985; 175():565-8. PubMed ID: 3887432
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
    Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
    Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Massive chemotherapy and purged bone marrow autograft in severe neuroblastoma. Preliminary results apropos of 5 cases].
    Frappaz D; Philip T; Philip I; Biron P; Bouffet E; Favrot M; Veley B; Martinez MF; Lacroze M; Dutou L
    Pediatrie; 1985; 40(7):539-51. PubMed ID: 3913896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
    Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
    Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary M; Harris RE; Selch M; Atkinson JB; Haase G; Hammond GD
    Prog Clin Biol Res; 1994; 385():301-7. PubMed ID: 7972225
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intensive chemotherapy followed by autologous bone marrow transplantation in solid tumors in childhood].
    de Kraker J; Voûte PA; Behrendt H
    Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2302-5. PubMed ID: 6392905
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
    Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
    Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo-radiotherapy and autologous bone marrow transplantation in poor prognosis neuroblastoma.
    Franzone P; Scarpati D; Vitale V; Corvó R; Barra S; Guenzi M; Orsatti M; Dini G
    Radiother Oncol; 1990; 18 Suppl 1():102-4. PubMed ID: 2247630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
    Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unpurged ABMT for neuroblastoma: AIEOP-BMT experience.
    Dini G; Lanino E; Garaventa A; Paolucci P; Amici A; Locatelli F; Colleselli P; Boni L; Dallorso S; Abla O
    Bone Marrow Transplant; 1991; 7 Suppl 2():92. PubMed ID: 1878740
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
    Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
    Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.